Related Experiment Video

Updated: Sep 25, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy

E M Scholten1, J W de Fijter, L C Paul

  • 1Department of Nephrology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Current Drug Targets. Cardiovascular & Haematological Disorders
|May 29, 2003
PubMed

Insights

This review examines drug therapies for preventing and treating chronic allograft nephropathy (CAN). It evaluates current immunosuppressive and non-immune treatments, assessing their long-term efficacy and impact on survival markers.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Chronic allograft nephropathy (CAN) is a major cause of kidney transplant failure.
  • Effective long-term management strategies for CAN are crucial for improving patient outcomes.

Purpose of the Study:

  • To review existing evidence on drug therapies for preventing and treating chronic allograft nephropathy (CAN).
  • To evaluate the efficacy of current immunosuppressive and non-immune therapies for CAN risk factors.
  • To explore potential benefits of novel therapeutic approaches for CAN.

Main Methods:

  • Literature review of studies on drug therapy for chronic allograft nephropathy.
  • Analysis of immunosuppressive and non-immune treatment strategies.
  • Evaluation of treatment efficacy based on long-term outcomes and survival markers.

Main Results:

  • Evidence suggests drug therapy can play a role in preventing and treating CAN.
  • Current therapies target risk factors, with varying efficacy on long-term outcomes.
  • Emerging approaches show promise, primarily from in vitro and animal studies.

Conclusions:

  • Drug therapies offer potential for managing chronic allograft nephropathy (CAN).
  • Further research is needed to validate novel approaches in clinical settings.
  • Optimizing treatment strategies is key to improving long-term kidney allograft survival.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...